The live, on-stage demo will take place on September 18 at noon PT at the Santa Clara Convention Center
San Francisco, CA, September 10, 2018 — Feel Therapeutics, Inc., a developer of artificial emotional intelligence technology, today announced that George Eleftheriou, CEO of Feel Therapeutics, will do a live, on-stage demo of Feel at the Health 2.0 Conference and present the company’s vision for Augmented Mental Health. The presentation will take place as part of “The Quantified Self: A New Generation of Personal Tracking” session on September 18 between 12-1pm PT at the Santa Clara Convention Center, Grand Ballroom C. Feel Therapeutics will also showcase its solutions at the event at its booth # 215.
Feel is the world’s first emotion sensor and mental health advisor. It consists of 3 parts: the Wristband, Proprietary Algorithms, and the Mobile Application. The emotion sensing wristband has integrated bio-sensors that monitor a variety of physiological signals throughout the day, while in the background, proprietary algorithms analyze these signals to recognize the wearer’s emotions. The mobile application receives the data from the wristband and monitors the emotions of the user, providing personalized recommendations as well as real-time coaching and intervention based on the principles of evidence-based techniques.
Feel Therapeutics' program for Augmented Mental Health includes all of the following:
Feel Therapeutics, Inc. is developing Digital Biomarkers and Therapeutics to bring objective data and measurement in the way we diagnose, manage, and care for Mental Health. The company is backed by top-tier investors (Felicis, Anthemis, SOSV) and has partnerships with large pharmaceutical companies to develop novel digital biomarkers and bring digital health solutions to market as standalone programs or alongside medications. Feel Therapeutics is headquartered in San Francisco, with additional offices in Europe. For more information, visit http://www.feeltherapeutics.com or contact us at email@example.com.